Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

Ph II Atezolizumab as Thrpy in Pts w/ Stage Ib, II, Or IIIa Resectable & Untreated NSCLC

Protocol: OSU-16157

Full Title

A Phase II, Open-Label, Multicenter, Single-Arm Study To Investigate The Efficacy And Safety Of Atezolizumab As Neoadjuvant And Adjuvant Therapy In Patients With Stage IB, II, IIIA, or Selected IIIB Resectable And Untreated Non-Small Cell Lung Cancer